PTGX Financials

Protagonist Therapeutics Inc - Financial statements & key metrics

Stock Price

$146.50

Market Cap

$7.25B

P/E Ratio

121.6

EPS

$0.66

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$275.19M

EPS (Diluted)

$4.23

Balance Sheet Highlights

Total Assets

$744.73M

Total Liabilities

$69.43M

Shareholders Equity

Cash & Equivalents

$97.25M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$184.15M

CapEx

Free Cash Flow

Profitability Metrics

Operating Margin

-985.2%

Net Margin

21.9%

ROE

7.8%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is PTGX revenue?

View PTGX's income statement for detailed revenue data.

Is PTGX profitable?

PTGX reported a profit of $275.19M in the most recent quarter. The net profit margin is 21.9%.

What is PTGX market cap?

PTGX has a market capitalization of $7.25B, making it a mid-cap stock.

Does PTGX have debt?

View PTGX's balance sheet for debt information.

What is PTGX cash flow?

Cash flow data is available in the full financial statements.